191 related articles for article (PubMed ID: 29140557)
1. WITHDRAWN: Pharmacological cardioversion for atrial fibrillation and flutter.
Cordina J; Mead GE
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD003713. PubMed ID: 29140557
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological cardioversion for atrial fibrillation and flutter.
Cordina J; Mead G
Cochrane Database Syst Rev; 2005 Apr; (2):CD003713. PubMed ID: 15846675
[TBL] [Abstract][Full Text] [Related]
3. Electrical cardioversion for atrial fibrillation and flutter.
Mead GE; Flapan AD; Elder AT
Cochrane Database Syst Rev; 2002; (1):CD002903. PubMed ID: 11869642
[TBL] [Abstract][Full Text] [Related]
4. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.
Kukendrarajah K; Ahmad M; Carrington M; Ioannou A; Taylor J; Razvi Y; Papageorgiou N; Mead GE; Nevis IF; D'Ascenzo F; Wilton SB; Lambiase PD; Morillo CA; Kwong JS; Providencia R
Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013255. PubMed ID: 38828867
[TBL] [Abstract][Full Text] [Related]
5. WITHDRAWN: Electrical cardioversion for atrial fibrillation and flutter.
Mead GE; Elder A; Flapan AD; Cordina J
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD002903. PubMed ID: 29140555
[TBL] [Abstract][Full Text] [Related]
6. Electrical cardioversion for atrial fibrillation and flutter.
Mead GE; Elder AT; Flapan AD; Kelman A
Cochrane Database Syst Rev; 2005 Jul; (3):CD002903. PubMed ID: 16034878
[TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
Lafuente-Lafuente C; Valembois L; Bergmann JF; Belmin J
Cochrane Database Syst Rev; 2015 Mar; (3):CD005049. PubMed ID: 25820938
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic Cardioversion of Recent-Onset Atrial Fibrillation and Flutter in the Emergency Department: A Systematic Review and Network Meta-analysis.
deSouza IS; Tadrous M; Sexton T; Benabbas R; Carmelli G; Sinert R
Ann Emerg Med; 2020 Jul; 76(1):14-30. PubMed ID: 32173135
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of pad placement for electrical cardioversion of atrial fibrillation/flutter: a systematic review.
Kirkland S; Stiell I; AlShawabkeh T; Campbell S; Dickinson G; Rowe BH
Acad Emerg Med; 2014 Jul; 21(7):717-26. PubMed ID: 25117151
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation.
Nyong J; Amit G; Adler AJ; Owolabi OO; Perel P; Prieto-Merino D; Lambiase P; Casas JP; Morillo CA
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012088. PubMed ID: 27871122
[TBL] [Abstract][Full Text] [Related]
11. Concomitant atrial fibrillation surgery for people undergoing cardiac surgery.
Huffman MD; Karmali KN; Berendsen MA; Andrei AC; Kruse J; McCarthy PM; Malaisrie SC
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011814. PubMed ID: 27551927
[TBL] [Abstract][Full Text] [Related]
12. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
[TBL] [Abstract][Full Text] [Related]
13. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
Valembois L; Audureau E; Takeda A; Jarzebowski W; Belmin J; Lafuente-Lafuente C
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD005049. PubMed ID: 31483500
[TBL] [Abstract][Full Text] [Related]
14. The RACE study in perspective of randomized studies on management of persistent atrial fibrillation.
Hagens VE; Van Gelder IC; Crijns HJ;
Card Electrophysiol Rev; 2003 Jun; 7(2):118-21. PubMed ID: 14618033
[TBL] [Abstract][Full Text] [Related]
15. Dofetilide: a review of its use in atrial fibrillation and atrial flutter.
McClellan KJ; Markham A
Drugs; 1999 Dec; 58(6):1043-59. PubMed ID: 10651390
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological therapy of atrial fibrillation and atrial flutter].
Grönefeld GC; Li YG; Hohnloser SH
Herz; 2002 Jun; 27(4):329-44. PubMed ID: 12187863
[TBL] [Abstract][Full Text] [Related]
17. Factors predicting maintenance of sinus rhythm after direct current cardioversion of atrial fibrillation and flutter: a reanalysis with recently acquired data.
Arnar DO; Danielsen R
Cardiology; 1996; 87(3):181-8. PubMed ID: 8725311
[TBL] [Abstract][Full Text] [Related]
18. Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter.
Howard PA
Ann Pharmacother; 1999 Jan; 33(1):38-47. PubMed ID: 9972384
[TBL] [Abstract][Full Text] [Related]
19. Risks and benefits of rate control versus maintenance of sinus rhythm.
Saxonhouse SJ; Curtis AB
Am J Cardiol; 2003 Mar; 91(6A):27D-32D. PubMed ID: 12670639
[TBL] [Abstract][Full Text] [Related]
20. Dronedarone for the treatment of atrial fibrillation and atrial flutter.
Maund E; McKenna C; Sarowar M; Fox D; Stevenson M; Pepper C; Palmer S; Woolacott N
Health Technol Assess; 2010 Oct; 14(Suppl. 2):55-62. PubMed ID: 21047492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
